Concomitant activation of miR-107/PDCD10 and hypoxamir-210/Casp8ap2 and their role in cytoprotection during ischemic preconditioning of stem cells.
about
Bone marrow mesenchymal stem cell therapy in ischemic stroke: mechanisms of action and treatment optimization strategiesHypoxamiRs and cancer: from biology to targeted therapyOxymiRs in cutaneous development, wound repair and regenerationSerum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of gliomaHypoxic Preconditioning Increases Survival and Pro-Angiogenic Capacity of Human Cord Blood Mesenchymal Stromal Cells In Vitro.miR-210: fine-tuning the hypoxic response.Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epitheliumStem cell-based delivery of Hypoxamir-210 to the infarcted heart: implications on stem cell survival and preservation of infarcted heart functionmicroRNA-206 is involved in survival of hypoxia preconditioned mesenchymal stem cells through targeting Pim-1 kinase.Priming adult stem cells by hypoxic pretreatments for applications in regenerative medicine.Preconditioning strategy in stem cell transplantation therapy.Emerging roles of miR-210 and other non-coding RNAs in the hypoxic response.Concise review: MicroRNA function in multipotent mesenchymal stromal cells.Hypoxic regulation of the noncoding genome and NEAT1.A brief review: the therapeutic potential of bone marrow mesenchymal stem cells in myocardial infarction.EGCG ameliorates the hypoxia-induced apoptosis and osteogenic differentiation reduction of mesenchymal stem cells via upregulating miR-210.
P2860
Q26740083-657E153D-962D-44D8-9710-5888D4729A8FQ26863298-E599C164-13EB-4418-8C8B-48D74B36B960Q27024906-C2021DE4-ECC5-4CAD-BB41-1FC5832ECF63Q35275041-925B2E87-18E5-42E3-AA1A-298600100AADQ35779127-7EF00258-46FF-4EA7-B953-79B5B996E080Q35891149-0D125BA7-3940-471C-AB0A-AFC057F79158Q36089079-F83A4B29-EC7D-4689-838C-2762F200BBE8Q36177022-A5973B75-AFED-4904-8856-A97E2656023CQ36825594-FACBB9F6-7669-400B-9DE1-67ECF048D691Q37153287-31F23F56-F81F-4019-8A3F-0B265F4D5EC7Q38126494-0E823A1E-CCBE-4D70-BE38-787AF0C58D22Q38176255-95A85661-064C-4C29-9831-5BC8372995B9Q38214780-EF7B7DF5-A5FD-423A-898F-AA32E035D5BEQ42070258-2ED67E56-854C-4B18-982F-D2F59BCD9D15Q47137130-B2D5896A-2ED7-436B-95EC-84ACEDB2CE9FQ51554895-85B3E9FE-A94C-4A3E-A7D0-9EFFEF0ACB11
P2860
Concomitant activation of miR-107/PDCD10 and hypoxamir-210/Casp8ap2 and their role in cytoprotection during ischemic preconditioning of stem cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Concomitant activation of miR- ...... preconditioning of stem cells.
@ast
Concomitant activation of miR- ...... preconditioning of stem cells.
@en
type
label
Concomitant activation of miR- ...... preconditioning of stem cells.
@ast
Concomitant activation of miR- ...... preconditioning of stem cells.
@en
prefLabel
Concomitant activation of miR- ...... preconditioning of stem cells.
@ast
Concomitant activation of miR- ...... preconditioning of stem cells.
@en
P2093
P2860
P356
P1476
Concomitant activation of miR- ...... preconditioning of stem cells.
@en
P2093
Faryal Mallick
Ha Won Kim
Khawaja Husnain Haider
Muhammad Ashraf
Shazia Durrani
Shujia Jiang
P2860
P304
P356
10.1089/ARS.2012.4518
P577
2012-05-23T00:00:00Z